Short Title:
2026 CVD/Late CNS biomarker & CM Val
Responsible HRP Element:
Space Radiation
Funding Status:
Planned-Funded - Task expected to be within budget
Procurement Mechanism(s):
|
|
Aims:
-
Aim 1 (CVD): Validate efficacy of standard of care clinical protective measures in a combined stressor model with chronic mixed field exposures, evaluating for mitigation of radiation-induced CVD.
-
Aim 2 (CVD/CNS): Validate efficacy of cross-risk candidate radioprotective agents in a combined stressor model with chronic mixed field exposures, evaluating for mitigation of radiation-induced CVD and late CNS adverse outcomes.
-
Aim 3 (CVD, CNS): Evaluate any potential antagonistic, synergistic, or additive effects across CVD protective measures and late CNS adverse outcomes.
Category:
Countermeasure
Subcategory:
Clinical Procedure/Prescription
Description:
Validated medical countermeasures to mitigate CVD and late neurodegenerative diseases from the combined stressors of spaceflight.
Internal Customers:
None
External Customers:
None